GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | DIABLO | affects localization | EXP | | 6480464 | CTD | alvocidib affects the localization of DIABLO protein | PMID:12517783 | DIABLO | multiple interactions | EXP | | 6480464 | CTD | [alvocidib co-treated with Bortezomib] results in increased secretion of DIABLO protein; [alvocidib co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] affects the localization of DIABLO protein; [Imatinib Mesylate co-treated with alvocidib] results in increased secretion of DIABLO protein | PMID:12231544 PMID:15039284 PMID:15634644 | |
Go Back to source page | Continue to Ontology report |